Prior IV thrombolysis does not dictate first-line thrombectomy technique
For neurology and neurointerventional pharmacists, this secondary analysis clarifies that alteplase exposure before thrombectomy should not, by itself, drive selection of aspiration versus combined stent-retriever strategies.
Does prior thrombolysis influence thrombectomy effectiveness in stroke recovery?
The impact of prior intravenous thrombolysis (IVT) on thrombectomy strategies for stroke remains uncertain, affecting clinical decision-making. In the VECTOR trial's secondary analysis, prior IVT did not significantly alter reperfusion success between thrombectomy strategies, though a slight advantage for contact aspiration (CA) was noted in non-IVT patients. Both contact aspiration and stent retriever plus contact aspiration are viable regardless of IVT use; findings are preliminary and specific to MRI-selected patients using alteplase. Prior IVT does not notably affect thrombectomy strategy outcomes, suggesting broad applicability of techniques.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Authors:Mouyal SJ, Maïer B, Labreuche J, Desilles JP, Mazighi M, Bourcier R, Redjem H
Citation:Mouyal SJ, Maïer B, Labreuche J, et al. Impact of prior intravenous thrombolysis on first-line thrombectomy strategy. A secondary analysis of the VECTOR trial. European stroke journal. 2026;11(7). doi:10.1093/esj/aakag087
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?
Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.